News Category
Viromed Medical AG signs distribution partnerships for its ViroCAP® device in six new markets, projecting at least 3,000 additional device sales per y...
Quantum BioPharma received FDA clearance to begin Phase 2 trials for its novel MS candidate Lucid-MS, which targets myelin repair rather than immune m...
PX1 Research introduces a new line of sublingual peptide strips manufactured in the U.S., offering needle-free alternatives for Retatrutide, Tirzepati...
PX1 Research's new domestic manufacturing protocol applies cGMP quality control and seven-stage HPLC purity verification, ensuring 99%+ purity with ba...
NanoViricides has received regulatory approval to begin a Phase II trial of its oral antiviral NV-387 for Ebola, potentially offering a more accessibl...
University of Virginia scientists find focused ultrasound may make brain tumors more susceptible to cancer drugs, offering a targeted approach that co...
Telomir Pharmaceuticals announced peer-reviewed preclinical data showing Telomir-Zn suppresses tumor growth in prostate and triple-negative breast can...
Park-Ohio's second-quarter earnings beat estimates, with record gross margins and raised guidance, indicating a turnaround in its core portfolio despi...
ICON Smile Studios opens two flagship multidisciplinary campuses in Virginia Beach and Norfolk, uniting orthodontics, periodontics, and pediatric dent...
Scinai Immunotherapeutics strengthens its CDMO platform with the appointment of Eran Kuratz as head of supply chain and business process administratio...
Quantum BioPharma's FDA approval to begin Phase 2 trials for its novel MS drug Lucid-MS could herald a shift from immune-modulating therapies to neuro...
Tonix Pharmaceuticals' Q2 2026 revenue surged to $13.5 million, driven by TONMYA's strong sales, while the company progresses its clinical pipeline an...
Tonix Pharmaceuticals announced Q2 2026 revenue of $13.5 million, up from $2 million a year ago, fueled by TONMYA sales, and provided updates on its p...
Tonix Pharmaceuticals reported strong Q2 2026 results with TONMYA driving revenue growth and promising pipeline advances, positioning the company for ...
Voyageur Pharmaceuticals advances its proprietary iodine extraction process with 99.8% purity results and plans field pilot testing, aiming to establi...
OffScript introduces two sublingual nootropic mint lines with complete ingredient transparency and third-party testing, catering to the growing demand...
A comprehensive review in the World Journal of Pediatric Surgery offers a unified framework for diagnosing and treating neuroblastoma, emphasizing ris...
Regentis Biomaterials is progressing its GelrinC cartilage regeneration technology through key clinical and regulatory milestones, potentially offerin...
Quantum BioPharma is progressing its two-pronged approach to neurological health, targeting multiple sclerosis with Lucid-MS and alcohol-related effec...
Quantum BioPharma is progressing two distinct approaches—an investigational MS therapy and a dietary supplement—to address neurological and alcohol-re...
VERAXA Biotech's advanced antibody engineering platform positions it to capitalize on significant pharmaceutical investment in ADCs and T-cell engager...
A case in Spain where a patient's pork tapeworm infection mimicked brain cancer highlights the dangers of undercooked pork and the urgent need for imp...
Veetee USA's appointment of Kevin Stitt signals a strategic push to grow its ready-rice brand in major U.S. retailers with a differentiated product an...
Lantern Pharma announces its Q2 2026 earnings webcast, providing updates on its AI-driven oncology pipeline and the commercial launch of its withZeta....
Earth Science Tech's fiscal first-quarter net income surged 57% year-over-year, signaling robust growth in its healthcare platform and improved financ...
Thorium Atomics has initiated pre-application regulatory engagement with the U.S. Nuclear Regulatory Commission for its Tesseract TGR advanced reactor...
VERAXA Biotech has advanced its VXA-222 bispecific antibody-drug conjugate into the next development stage and expanded its IP portfolio, strengthenin...
American Fusion Inc. has filed six additional U.S. patent applications, bringing its total to 82, as it progresses toward OTCQB listing and prepares f...
Nano-X Imaging Ltd. announced an $8 million registered direct offering to a single institutional investor, with proceeds earmarked for working capital...
A novel liquid biopsy offers a simpler way to predict which advanced lung cancer patients will respond to immunotherapy, potentially improving treatme...
GeoVax announced completion of manufacturing, regulatory, clinical, and preclinical milestones for its mpox/smallpox vaccine GEO-MVA, supporting initi...
Innovative Designs, Inc. announces its best quarter ever with near 40% revenue growth and ongoing expansion, while finalizing independent lab re-certi...
The July Wellness Index Report from Wellness Eternal highlights a philosophical shift in longevity medicine toward supporting the body's natural proce...
The July Wellness Index Report reveals a pivotal change in longevity medicine, focusing on the body's own hormones, cells, and microbiome rather than ...
Regentis Biomaterials' next-generation manufacturing process for GelrinC, approved in Europe, increases yield by 400%, positioning the cell-free hydro...
Purple Exhibits enhances its KBIS 2027 exhibit services by having Joey Bartman oversee all projects, leveraging his expertise to ensure quality and su...
Onco-Innovations is combining PNKP-targeted therapy, nanoparticle delivery, and AI to develop ONC010, aiming to improve cancer treatment efficacy and ...
Earth Science Tech Inc. is strengthening its presence in the growing telehealth market through strategic investments, vertical integration, and propri...
Episode 812 of DH Unplugged covers volatile markets driven by Big Tech earnings, a Korean stock market crash, and SpaceX's post-IPO troubles.
Nagoya University researchers discovered that the ancient protein C3, when produced by tumor cells, may boost the effectiveness of immunotherapy by ac...
American Fusion Inc. presented its Texatron Fusion Engine development and related scientific research at the APS Division of Particles and Fields 2026...
VolitionRx's new Capture-Seq technology, detailed in a peer-reviewed paper, achieves over 99% pure ctDNA isolation, potentially transforming cancer de...
Tonix Pharmaceuticals announced its participation in two key investor conferences, providing a platform to discuss its commercial-stage CNS and immuno...
VERAXA Biotech has moved its VXA-222 bispecific antibody-drug conjugate program into the next development stage and expanded its intellectual property...
LataMed AI Corp. will participate in the Artificial Intelligence & Health Markets 2026 conference in Caracas, Venezuela, to discuss the role of AI in ...
NeuroThera Labs has initiated a Phase IIb clinical trial at Yale Child Study Center for SCI-110, a novel cannabinoid-based treatment for Tourette Synd...
Medios AG, a leading Specialty Pharma provider in Europe, has named Katrin Neuffer as its new Director of Investor Relations and Communications, effec...
SRX Global's investment in Vistagen Therapeutics signals a strategic move to unlock shareholder value in a neuroscience biopharmaceutical company.
